Report Overview: The Global Diagnostic Biomarkers Market achieved a valuation of $50.36 Billion in 2022 and is anticipated to exceed $123.84 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 11.9% during the forecast period from 2024 to 2032. Key Market Players: Biocrates Life Sciences AG, Augurex Life Sciences Corp., Biomedical Corp., Target Discovery,...